Medindia58m
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7-33. doi: 10.3322/caac.21708. [ii] Ettrich T J, Seufferlein T. Systemic ...
Medindia50m
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
Incyte (Nasdaq:INCY) and Syndax Pharmaceuticals (Nasdaq:SNDX) today announced that the U.S. Food and Drug Administration (FDA) has approved Niktimvo™ (axatilimab-csfr) in 9 mg and 22 mg vial sizes.
Medindia58m
Grateful Son JP Conte Fuels Research into Parkinson's Disease and other Brain Disorders
In November 2024, the JP Conte Family Foundation made a transformative $5 million gift to UCSF to establish two professorships in the Department of Neurology. These endowed positions, overseen by ...
Medindia57m
Registration open for 13th Annual Meeting of the Society of Hematologic Oncology
The Society of Hematologic Oncology (SOHO) has opened registration for its annual meeting; register before June 8, 2025, for early-bird rates. The meeting will include keynote lectures, panel ...